Business Responsibility and Sustainability Report for the Financial Year 2025-26

Ref: 22/SE/LC/2026-27 Date: July 27, 2026 Scrip Code BSE: 544122 NSE: ENTERO ISIN: INE010601016 Head, Listing Compliance Department Head, Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, Plot No. C/1. G Block, Mumbai - 400 001. Bandra -Kurla Complex, Bandra (East), Mumbai- 400051 Dear Sir/Madam, Subject: Business Responsibility and Sustainability Report for the Financial Year 2025- Pursuant to Regulation 34(2)(f) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Business Responsibility and Sustainability Report (‘BRSR’) for the Financial Year 2025-26. The BRSR forms part of the Annual Report of the Company for the Financial Year 2025-26. The above information is also made available on the website of the Company at www.enterohealthcare.com This is for your information and records. Yours faithfully, For Entero Healthcare Solutions Limited Sanu Kapoor Vice president- Group General Counsel, Company Secretary & Compliance Officer Encl: as above (2 Entero [ET— Business Responsibility And Sustainability Report In this report, the words - ‘The Company; ‘Entero, ‘We, ‘Our’ are used interchangeably to denote Entero Healthcare Solutions Limited and its subsidiaries SECTION A: GENERAL DISCLOSURES woNm®eg Details of the listed entity: Corporate Identity Number (CIN) of the Listed Entity- L74999HR2018PLC072204 Name of the Listed Entity - Entero Healthcare Solutions Limited Year of incorporation - 10/01/2018 Registered office address - Plot No. I-35, Building-B, Industrial Area Phase-l, 13/7 Mathura Road, Faridabad, Haryana - 121003 Corporate address - Entero House, Crystal Plaza, 158-C.S.T. Kalina Road, Mumbai - 400098, Maharashtra E-mail - investor.grievance@ehspl.com Telephone - +91-22-69019100 / +91-22-26529100 Website - www.enterohealthcare.com Financial yefora whrich reporting is being done - 1st April, 2025 to 31st March, 2026 Name of the Stock Exchange(s) where shares are listed: Name of the Exchange Stock Code BSE Ltd. 544122 National Stock Exchange of India Ltd. ENTERO 1. Paid-up Capital - INR 43,51,09,370/- 12. Name and contact details (telephone, email address) of the person who may be contacted in case of any queries on the BRSR report - Ms. Sanu Kapoor Tel: +91-22-69019100 Email id: investor.grievance@ehspl.com Reporting boundary - Are the disclosures under this report made on a standalone basis (i.e. only for the entity) or on a consolidated basis (i.e. for the entity and all the entities which form a part of its consolidated financial statements, taken together) - This report is prepared on a consolidated basis for Entero Healthcare Solutions Limited (“Entero” / “Company”/ “We"), encompassing its 48 subsidiaries. 14, Name of assurance provider - Not Applicable. 15. Type of assurance obtained - Not Applicable. Products/services 16. Details of business activities (accounting for 90% of the turnover): S.No. Description of Main Activity Description of Business Activity | % of Turnover of the entity 1| The Company and its subsidiaries are engaged in the | Distribution and Marketing of 100 Business of Distribution and Marketing of Pharmaceuticals, Surgical and other Pharmaceuticals, Surgical and other Healthcare and | Healthcare and Allied products Allied products. 17. Products/ Services sold by the entity (accountifnogr 9 0% of the entity's Turnover): S.No. Product/ Service NIC Code % of Turnover contributed 1| Distribution and Marketing of Pharmaceutical, 46497 100 Surgical and other Healthcare and Allied products. . Operations 8. Nuomf locbatioens whrere plants and/or operations/offices of the entiatrye ituated: Location Numbeorf Plants Number of Offices/Warehouses' Total National 0 137 137 International 0 0 0 Marservked bey thetentisty: Numofb loceatirons Locations Number National (No. of States & UTs) 21 States International (No. of Countries) 0 76 NEXT IS NOW EXPANDING HORIZONS IN HEALTHCARE STATUTORY REPORTS b. What is the contribution of exports as a percentage of the total turnover of the entity? The Company operates exclusively within India and does not engage in export activities. Accordingly, the contribution of exports to the total turnover is not applicable. 3 A brief on types of customers: The Company operates in B2 segment. The customer base of Entero Healthcare Solutions Limited and its subsidiaries, consists of various segments within the Healthcare industry. This segment includes Retail Pharmacies, Hospitals & nursing homes and Institutions such as Clinics. Employees 20. Details as at the end of Financial Year: Employees and workers (including differently abled): S.No. Particulars Total (A) Male Female No.(B) | %(B/A) No.(© | %(C/A) EMPLOYEES 1. Permanent (D) 4671 3443 73.71 1228 2629 2. Other than Permanent (E) 272 204 75.00 68 25.00 3. Total employees (D +E) 4943 3647 73.78 1296 26.21 WORKERS 4. Permanent (F) 27 10 37.03 7 62.96 5. Other than Permanent (G) 0 0 0.00 0 0.00 6. Total workers (F + G) 27 10 37.03 17 62.96 Differentlyabled Employees and workers: S.No. Particulars Total (A) Male Female No.(B) | %(B/A) No.(© | %(C/A) DIFFERENTLY ABLED EMPLOYEES 1. | Permanent (D) ‘The Company does not have any Differently abled Employees 2. Other than Permanent (E) 3. | Total differently abled employees (D + E) DIFFERENTLY ABLED WORKERS 4. | Permanent (F) 5. Other than permanent (G) The Company does not have any Differently abled Workers 6. | Total differently abled workers (F + G) 21, ation/Inclusion/ Representation of women: S.No. Particulars Total (A) No. and percentage of Females No. (B) % (B/A) 1. | Board of Directors* 8 2 25.00 2. | Key Management Personnel** 2 1 50.00 *Note: The Board ofD irectors (BOD) includes the Managing Director & CEO and the Whole-Time Director. Here, the roles of Managing Director & CEOareheld by the same individual. **KMP’s include: Group Chief Financial Officer and General Counsel/Company Secretary/Compliance Offiof cEneterro. Turnoverrateforpermanent employeesand workin peercrents): S.No. Particulars FY 2024-25 FY 2024-25 FY 2023-24 Male | Female Total Male | Female | Total Male | Female Total 1. Permanent Employees 3433 37.56 35.94 3893 37.62 3827 37.84 36.40 3745 2. Permanent Workers 46.15 0.00 20.00 0.00 0.00 0.00 0.00 0.00 0.00 (2 Entero ANNUAL REPORT 2025-26 V. Holding, Subsidiaarnyd Associate Companies (including joint ventures) 23. (@ Namesofholding/subsidiary/associate companies/ jointventures S.No. Name of the holding/ subsidiary/ Indicate whether | % of shares | Does the entity indicated associate companies/ joint ventures (A) holding/ heldby | atcolumn A, participate Subsidiary/ | listed entity the Business Associate/ Responsibility initiatives Joint Venture of thelisted entity? (Yes/No) 1. | RSM Pharma Private Limited Subsidiary 100.00 Yes 2. | Jaggi Enterprises Private Limited Subsidiary 100.00 Yes 3. | G.SPharmaceutical Distributors Private Limited Subsidiary 100.00 Yes 4. | Novacare Healthcare Solutions Private Limited Subsidiary 100.00 Yes 5. | Chhabra Healthcare Solutions Private Limited Subsidiary 100.00 Yes 6. | Galaxystar Pharma Distributors Private Limited Subsidiary 100.00 Yes 7. | Sundarlal Pharma Distributors Private Limited Subsidiary 100.00 Yes 8| Millennium Medisolutions Private Limited Subsidiary 100.00 Yes 9. | Getwell Medicare Solution Private Limited Subsidiary 100.00 Yes 10._| Vasavi Medicare Solutions Private Limited Subsidiary 100.00 Yes 11 Avenues Pharma Distributors Private Limited Subsidiary 100.00 Yes 12. Chirag Medicare Solutions Private Limited Subsidiary 100.00 Yes 13. Chethana Healthcare Solutions Private Limited Subsidiary 100.00 Yes 14. Rada Medisolutions Private Limited Subsidiary 100.00 Yes 15. Chethana Pharma Private Limited Subsidiary 100.00 Yes 16. SVMED Solutions Private Limited Subsidiary 100.00 Yes 17. Sesha Balajee Medisolutions Private Limited Subsidiary 100.00 Yes 18. [Showing first 8,000 characters — download PDF for full document]